AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion By Leroy Leo and Patrick W...
2nd February, 2024
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion By Leroy Leo and Patrick W...
2nd February, 2024
Boeing execs stand by 2025-26 financial guidance; near-term focus is safety By Valerie Insinna and A...
31st January, 2024
Industry pain abounds as electric car demand hits slowdown By Nick Carey and Joseph White (Reuters)...
30th January, 2024
Holcim takes ‘rock star’ North American business to Wall Street By John Revill ZURICH (Reuters) – Ho...
29th January, 2024
Boeing under a microscope for safety issues as it reports results By Abhijith Ganapavaram and Valeri...
29th January, 2024
Italy’s Meloni seeks new partnership with Africa, funds limited By Crispian Balmer and Angelo Amante...
29th January, 2024
Faced with slow 5G rollout, EU telcos single out Big Tech again By Foo Yun Chee BRUSSELS (Reuters) –...
29th January, 2024
Investing Over 40 Years: Lessons from Eric Munson As recent market volatility unnerves investors, Er...
26th January, 2024
Explainer-What you need to know about the April total solar eclipse By Will Dunham WASHINGTON (Reute...
26th January, 2024
Tokyo Metro to go public as Japan seeks to reap benefits of buoyant stock market By Satoshi Sugiyama...
26th January, 2024
Europe will miss 2030 chip market goal, says ASML CEO By Toby Sterling AMSTERDAM (Reuters) – Europe...
25th January, 2024
Algotech Presale Raised $1.1 Million In 2 Days And is Transforming the DeFi Landscape London, United...
24th January, 2024